| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | May 20, 2025 | X4 Pharmaceuticals, Inc | Chief Commercial Officer | Buy | 82.5 | +1,032 | 4.25% | ✗ | $2.6K |
| May 17, 2024 | Feb 14, 2025 | X4 Pharmaceuticals, Inc | Chief Commercial Officer | Buy | 91.3 | +635,050 | 674.70% | ✗ | $19.3K |
| Jan 23, 2025 | Jan 27, 2025 | X4 Pharmaceuticals, Inc | Chief Commercial Officer | Sell | 91.3 | +45,614 | 94.03% | ✓ | $13.2K |
| Oct 4, 2024 | Oct 8, 2024 | X4 Pharmaceuticals, Inc | Chief Commercial Officer | Sell | 90.0 | +23,819 | 96.47% | ✓ | $6.5K |
| Nov 1, 2023 | Nov 3, 2023 | X4 Pharmaceuticals, Inc | Chief Commercial Officer | Sell | 15.0 | -10,257 | -29.35% | ✓ | $7.5K |